Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Cytovance Biologics, Inc., a leading full-service contract manufacturer (“CMO”) of mammalian and microbial biologics, announces a development and manufacturing agreement with Selexys Pharmaceuticals, Corp., an Oklahoma City-based clinical stage ...
read more
Thursday, February 27, 2014
Cytovance Biologics, Inc., a leading full-service contract manufacturer (“CMO”) of mammalian and microbial biologics, announces that they have entered into a development and manufacturing agreement with Pamlico Biopharma, Inc., an Oklahoma City-based...
read more
Thursday, October 03, 2013
Cytovance Biologics, a leading full-service contract manufacturer (“CMO”) of mammalian and microbial biologics, announces that they have entered into a manufacturing agreement with Translational Sciences, Inc., a Memphis, Tennessee-based clinical ...
read more
Cytovance Biologics, Inc., a leading full-service contract manufacturer of mammalian and microbial biologics, has recently been named as one of Oklahoma City’s fastest growing private companies.
read more
Cytovance Biologics, a leading full-service contract manufacturing organization (“CMO”) of mammalian and microbial biologics, welcomes Mark Ambrose, Ph.D., as Senior Director of Quality Systems and Compliance and Anne Garstka as Director of ...
read more
Cytovance Biologics has announced the addition of an integrated single-use platform for the manufacturing of plasmid DNA (pDNA) at their facilities in Oklahoma City, OK.
read more
Thursday, February 06, 2014
Cytovance Biologics, Inc., a leading full-service contract manufacturer of mammalian and microbial biologics, broke ground on an expansion facility to contain both manufacturing operations and GMP warehousing. The multi-million dollar capital ...
read more
Monday, November 11, 2013
Cytovance Biologics, a leading full-service contract manufacturer (“CMO”) of mammalian and microbial biologics, announces Jesse McCool as Vice President of Microbial Services.
read more
Wednesday, October 03, 2018
CytoSen Therapeutics and KBI Biopharma announced a strategic partnership to manufacture therapeutic Natural Killer cells using a proprietary and scalable, closed system manufacturing process.
read more
Friday, February 11, 2022
CytoReason has established itself as a global leader in computational modeling of human diseases. The company's multidisciplinary team of 65 leading biologists, bioinformaticians and data engineers has developed a technology that enables pharma and ...
read more
Thursday, September 08, 2022
Cytel expanded its operations into the Asia-Pacific region (APAC). This enables biotech and biopharma companies in APAC to have easier access to Cytel’s established biometrics and advanced statistical solutions.
read more
Cytel Inc. has appointed Albert Kim, MD, PhD, as its first Chief Medical Officer (CMO), driving expansion of the advanced analytics capabilities available to clinicians looking to streamline therapeutic development.
read more
Jason Mitakidis, President and CEO of Cyclica, Peter Pekos, President and CEO of Dalton Pharma Services and Dr. Judd Berman, Co-Founder of Dalton Medicinal Chemistry today announced a collaboration for the joint identification and development of a ...
read more
CyanVac announced they have selected Exothera for the development and manufacturing of their COVID-19 intranasal vaccine based on a proprietary parainfluenza virus 5 (PIV5) vector.
read more
Wednesday, March 30, 2022
CVS Health has entered into an agreement with the State of Florida to resolve claims dating back more than a decade related to prescriptions for opioid medications that were filled at Florida CVS Pharmacy locations.
read more